COMMUNIQUÉS West-GlobeNewswire

Ipsen réalise d’excellents résultats au premier semestre 2026 et relève ses objectifs financiers annuels
30/07/2026
Croissance semestrielle du chiffre d’affaires du Groupe de 23,5 % à taux de change constant 1 (20,4 % en données publiées), tirée par une croissance de 24,8 % des ventes du portefeuille de médicaments hors Somatuline [...]
Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance
30/07/2026
H1 2026 results with sales growth of 23.5% at CER 1 , or 20.4% as reported, with the portfolio beyond Somatuline ® achieving sales growth of 24.8% 1 and core operating income of €845m, growing by 28.8% as reported, with [...]
Communiqué de presse : T2 2026 : croissance à deux chiffres du chiffre d’affaires et forte progression du BNPA ; révision à la hausse des perspectives 2026
30/07/2026
T2 2026 : croissance à deux chiffres du chiffre d’affaires et forte progression du BNPA ; révision à la hausse des perspectives 2026 Paris, le 30 juillet 2026 Ventes du T2 en progression de 17,8 % à TCC 1 et BNPA 2 des [...]
Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded
30/07/2026
Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded July 30, 2026 Q2 sales growth of 17.8% at CER 1 and business earnings per share (EPS) 2 of €2.09 Pharma launches sales increased [...]
Sugar Reset Drops Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
30/07/2026
Sugar Reset Drops' Chromium Dose, Grapefruit and Licorice Interaction Details, and 20% Refund Fee Explained Largo, FL, July 30, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug [...]
Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine
30/07/2026
Proposed expansion in the Cluj-Napoca region intended to strengthen PET imaging supply and support continued development of regional nuclear medicine services BOSTON, July 30, 2026 (GLOBE NEWSWIRE) -- Curium™ announced [...]
AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa
30/07/2026
AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa Nippon Shinyaku exercises its exclusive U.S. commercialization option for Tadekinig alfa after AB2 Bio’s [...]
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
30/07/2026
Expanding indications for RYONCIL in children and adults with life-threatening inflammatory diseases Achieved target of at least 300 Patients treated in Pivotal Phase 3 trial for Chronic Low Back Pain Activity Report [...]
Daxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in Kansas
30/07/2026
Commercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader [...]
BRAVE Providers, LLC Launches The BRAVE Method, an Organizational Training Program Addressing Vicarious Trauma and Resilience in Trauma-Exposed Organizations
30/07/2026
Developed by trauma psychologist Jenny Hughes, PhD, the evidence-informed training gives groups, agencies, and organizations a shared framework for building vicarious resilience and retaining trauma clinicians. Houston [...]
FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.
29/07/2026
Room-temperature-stable and rapidly reconstituted, this first FDA-licensed product brings new options to emergency and remote settings Silver Spring, MD, July 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
Conavi Medical Corp. Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
29/07/2026
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES FINAL PROSPECTUS WILL BE ACCESSIBLE ON SEDAR+ TORONTO, July 29, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ [...]
Inventiva annonce ses résultats financiers préliminaires pour le premier semestre 2026¹
29/07/2026
Trésorerie et équivalents de trésorerie de 166,1 millions d'euros et 67,8 millions d'euros de dépôts à court terme 2 au 30 juin 2026 Daix (France), New York City (New York, États-Unis), le 29 juillet, 2026 – Inventiva ( [...]
Inventiva Announces Preliminary Financial Results for the First Half of 2026¹
29/07/2026
Cash and cash equivalents at €166.1 million and €67.8 million in short-term deposits 2 as at June 30, 2026 Daix (France), New York City (New York, United States), July 29, 2026 – Inventiva (Euronext Paris and NASDAQ: [...]
MIMEDX to Acquire Sanara MedTech
29/07/2026
Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategic Priority to Expand Surgical Footprint, Nearly Doubling Surgical Revenue [...]
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
29/07/2026
IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter [...]
60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026
29/07/2026
Company plans to request an FDA meeting following the interim readout to discuss the regulatory pathway for a New Drug Application (NDA) for tafenoquine in babesiosis WASHINGTON, July 29, 2026 (GLOBE NEWSWIRE) -- 60 [...]
Teladoc Health Reports Second Quarter 2026 Results
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless [...]
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
29/07/2026
SEATTLE, July 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive [...]

Pages